Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Avelumab/Gemcitabine in Sarcomatoid RCC
- Status
- TERMINATED
- Phase
- PHASE1
Durvalumab and Tremelimumab With Gemcitabine or Gemcitabine/Cisplatin Compared to Gemcitabine/Cisplatin in CCA Patients
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine Plus Ascorbate for Sarcoma in Adults
- Status
- TERMINATED
- Phase
- PHASE2
Study on Decitabine Plus Carboplatin Versus Physician's Choice Chemotherapy in Recurrent, Platinum-resistant Ovarian Cancer.
- Status
- UNKNOWN
- Phase
- PHASE2
A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)
- Status
- COMPLETED
- Phase
- PHASE3
M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Gemcitabine + Carboplatin + Nivolumab Versus Gemcitabine + Oxaliplatin + Nivolumab in Cisplatin-ineligible Patients With Metastatic Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy and G-CSF for Mobilization
- Status
- COMPLETED
- Phase
- PHASE2
Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss
- Status
- TERMINATED
- Phase
- PHASE1
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2